Chinese stem cell therapy reverses heart failure in 90% of patients, landmark trial finds
A clinical trial in China has demonstrated that stem cell therapy can significantly improve heart function in patients with severe heart failure. The study showed that 90% of treated patients experienced restored heart tissue and reduced symptoms compared to a control group.
Why it matters
This breakthrough offers a potential alternative to heart transplants, which are limited by donor shortages, and could revolutionize the treatment of chronic cardiac conditions.
A groundbreaking stem cell therapy could reverse severe heart failure in 90 per cent of patients in a landmark clinical trial in China, a new study revealed.
Patients with heart failure show signs of shortness of breath, tiredness, swelling in the legs, rapid weight gain, and persistent coughing.
While heart transplants are the main treatment currently to cure the condition, donors are scarce.
Now, researchers at the Nanjing Drum Tower Hospital in China have shown that the stem cell therapy could induce new heart tissue growth and restore function in nine out of 10 heart failure patients, and help slow their cardiac muscle ageing .
In the trial, 10 patients were injected with stem cells that could grow and differentiate into specialised heart muscle cells.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in